The High Price of Uncertainty: Why Many FDA-Approved Cancer Drugs Lack Proven Clinical Benefits
The American healthcare landscape is bracing for a significant shift as the incidence of cancer continues to rise. By 2030, the number of new cancer cases in the United States…